SBC Medical Group Holdings (SBC) Q3 FY2026 earnings: revenue $59 million, up 35.1% on the year
SBC Medical Group Holdings Inc. (SBC) reported revenue of $59 million for Q3 FY2026, the quarter ended 30 September 2026, up 35.1% on the same quarter a year earlier. Net income was $16 million, up 22.4% on the year, and diluted earnings per share $0.15. The figures are the company's own, from the 10-Q it filed with the SEC on 13 November 2026.
Revenue
$59 million
+35.1% on the year · +19.1% on the quarter
Q4 FY2024Q3 FY2026
Operating margin
45.1%
36.6% a year earlier
Q4 FY2024Q3 FY2026
Net income
$16 million
+22.4% on the year · +46.8% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$0.15
+25.0% on the year · +50.0% on the quarter
Q4 FY2024Q3 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Revenue rose 35% in the quarter: Quarterly revenue was $59 million, up 35% year-over-year.
Operating income rose 66%: Income from operations was $26 million, with a 45% operating margin, compared with $15.9 million a year earlier.
Clinic network reached 293 locations: The clinic network had 293 locations at September 30, 2026, up 36 year-over-year across the support and partnership network.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
18.5
22.5
-20.9
-17.8%
Capital expenditure
1.0
0.1
0.0
+1,090.9%
+2,234.4%
Free cash flow
17.5
22.4
-20.9
-22.0%
Free cash flow margin
29.9%
45.6%
-48.3%
Cash from investing
-5.1
0.6
-12.2
Cash from financing
-5.1
-2.0
11.6
Depreciation and amortisation
1.2
1.1
0.7
+4.5%
+61.4%
Share-based compensation
0.0
n/a
0.0
Buybacks
0.0
n/a
2.6
Diluted shares, weighted
103m
103m
103m
0.0%
-0.1%
Shares outstanding at period end
103m
103m
103m
0.0%
0.0%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q3 FY2026
Q2 FY2026
Q3 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
287
264
248
+8.7%
+15.7%
Non-controlling interest
16.6
16.1
0.1
+3.4%
+23,344.6%
Debt
33.6
37.8
22.8
-11.0%
+47.6%
Operating lease liabilities
4.5
4.9
1.6
-7.3%
+190.3%
Finance lease liabilities
0.1
0.1
0.1
-18.5%
-54.0%
Other liabilities
83.1
84.0
48.8
-1.0%
+70.2%
Total liabilities and equity
425
407
321
+4.5%
+32.2%
Fixed assets
8.5
7.4
7.0
+15.0%
+21.9%
Goodwill
15.1
15.2
4.9
-0.7%
+206.1%
Intangible assets
45.2
45.7
23.3
-1.0%
+94.1%
Investments
2.2
1.6
n/a
+37.8%
Cash and equivalents
198
184
127
+7.7%
+55.7%
Inventory
2.9
3.0
1.7
-1.0%
+75.8%
Other assets
152
149
157
+2.0%
-2.9%
Total assets
425
407
321
+4.5%
+32.2%
Questions
What was SBC Medical Group Holdings' revenue in Q3 FY2026?
SBC Medical Group Holdings (SBC) reported revenue of $59 million for Q3 FY2026, the quarter ended 30 September 2026, up 35.1% on the same quarter a year earlier.
How much did SBC Medical Group Holdings earn in Q3 FY2026?
Net income for Q3 FY2026 was $16 million, up 22.4% on the year, and diluted earnings per share $0.15.
When did SBC Medical Group Holdings report Q3 FY2026 results?
SBC Medical Group Holdings filed its 10-Q for the quarter ended 30 September 2026 with the SEC on 13 November 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 September 2026, filed 13 November 2026: the filing.